Microchannel Biomimetic Nerve Scaffold for Axonal Alignment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nerve repair technologies, such as autologous nerve grafts and single-channel nerve guides, fail to effectively guide axonal regeneration due to misalignment and lack of three-dimensional organization, leading to incomplete functional recovery and painful neuroma formation.
Innovation Solution
Development of biomimetic scaffolds with multiple microchannels and overhangs for nerve repair, incorporating biofunctional agents and 3D printing, to guide and support axonal regeneration across nerve gaps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a single large diameter tube scaffold is used, then the scaffold structure is simple and easy to manufacture, but axonal alignment is lost and regenerating axons become misaligned with their proper targets
Solution Approach 1:
The single large diameter tube scaffold is segmented into multiple microchannels (e.g., 6-12 channels) within the scaffold structure. Each microchannel has a diameter of 50-200 μm, which matches the size of peripheral nerve fascicles. This segmentation allows individual axons to maintain alignment within each microchannel while the overall scaffold remains manufacturable using techniques like 3D printing or micromolding.
Solution Approach 2:
The invention transitions from a single-dimensional large tube approach to a multi-dimensional microchannel array. The microchannels are arranged in specific patterns (hexagonal, circular, or rectangular arrays) that preserve spatial organization of axons. This dimensional transformation enables precise control over axonal trajectories while maintaining scaffold manufacturability through standardized microfabrication processes.
2Reliability
If multiple microchannels are incorporated in the scaffold, then axonal alignment and guidance are improved, but the device complexity and manufacturing difficulty increase
Solution Approach 1:
The scaffold design optimizes microchannel parameters including diameter (50-200 μm to match fascicle sizes), length (to bridge the nerve gap), and spacing (to accommodate multiple fascicles). The microchannels are positioned at specific angles and orientations to guide axons along physiologically relevant pathways. These parameter optimizations enhance guidance accuracy while keeping the overall structure compatible with standard manufacturing capabilities.
Solution Approach 2:
The scaffold employs composite materials that combine structural integrity with biocompatibility and degradability. Common composites include polycaprolactone (PCL) with gelatin methacryloyl (GelMA), or PCL with collagen. These composite materials provide the mechanical strength needed for complex multi-channel structures while maintaining a permissive environment for axonal growth and eventual degradation as native tissue regenerates.
3Reliability
If Schwann cells are used to fill the conduit, then natural support for axonal regeneration is improved, but the therapy has not been translated for human peripheral nerve injury
Solution Approach 1:
The scaffold acts as an intermediary structure that can accommodate different cell types including Schwann cells, stem cells, or growth factors. The microchannel architecture provides a standardized platform that can be filled with various biological agents depending on the specific clinical application. This intermediary design enables the same scaffold structure to be adapted for human peripheral nerve injury by simply changing the cellular or molecular contents, thereby improving clinical translation applicability.
Solution Approach 2:
The scaffold design is created as a universal platform that can serve multiple functions: structural support for nerve regeneration, delivery vehicle for growth factors or cells, and template for tissue organization. The multi-functional design allows the same scaffold to be used across different species and injury types, facilitating translation from animal models to human clinical applications by maintaining the core architectural principles while adapting the biological contents.
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Biomimetic scaffolds for neural tissue growth are disclosed herein which have a plurality of microchannels disposed within a sheath. Each microchannel comprises a porous wall that is formed from a biocompatible and biodegradable material. The biocompatible and biodegradable material may be polyethylene glycol) diacrylate, methacrylated gelatin, methacrylated collagen, or polycaprolactone, and combinations thereof. The biomimetic scaffolds have high open volume % enabling superior (linear and high fidelity) neural tissue growth, while minimizing inflammation near the site of implantation in vivo.